查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197874

氧合器市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Oxygenators Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在 2022 年至 2027 年的预测期内，氧合器市场的复合年增长率为 5.4%。

为应对当前的 COVID-19 形势，公司正在全球范围内提高氧合器的产量，以支持采用 ECMO 程序治疗 COVID-19 患者。 ICU 病房对氧气呼吸器的需求显着增加。 此外，市场参与者正在推出氧合器相关产品，因为这些设备代表了 COVID-19 患者外科手术和管理中重症监护的最重要方面。 COVID-19 还影响了 2020 年氧气呼吸器产品的生产。 此外，由于 COVID-19 相关措施导致择期手术的延误对氧气呼吸器等医疗设备产生了负面影响，尤其是在 2020 年上半年。

推动市场增长的主要因素是由于生活方式的改变导致各种冠心病和中风的全球流行、外科手术的增加、有利的报销措施以及老年人口的快速增长。 例如，根据世界卫生组织的数据，2019 年约有 1790 万人死于心血管疾病，占全球所有死亡人数的 32%，直接导致冠状动脉搭桥手术的需求增加以及对高效治疗的需求。在整个预测期内，用于医疗器械的人工肺正在推动市场增长。

此外，心血管疾病的负担在世界范围内不断增加，并且是导致死亡的主要原因。 根据世界卫生组织 (WHO) 提供的 2020 年统计数据，缺血性心脏病占全球所有死亡人数的 16%。 据同一消息来源称，2019 年估计有 890 万人死于缺血性心脏病。 心血管疾病患病率上升正在推动心肺手术和冠状动脉旁路移植术 (CABG)，这可能会增加对氧合器的需求。

然而，采用微创手术（例如经皮冠状动脉介入治疗）、与氧气输送系统相关的风险以及美国 FDA 对必须满足性能标准的 II 类设备的严格规定阻碍了整个市场的增长。它作为因素

氧合器市场趋势

膜氧合器领域有望占据最大市场份额

与气泡式氧合器相比，膜式氧合器可以抑制组织损伤和血栓形成。它被周期性采用，预计在预测期内将占据最大的市场份额。 此外，它的快速部署、在相对较小的膜表面积上进行有效的气体交换、改善血流、减少溶血和减少术后出血是推动这一领域增长的进一步因素。

按应用来看，呼吸领域预计在预测期内将占据很大的市场份额。 这可能是由于慢性阻塞性肺病 (COPD) 和心肺疾病的患病率增加所致。

此外，2020 年 4 月，由印度科技部 (DST) 资助的印度公司 Genrich Membranes 开发了一种用于治疗 COVID-19 患者的膜氧合器。底部。 因此，随着早期未决操作的恢復，公司正在努力製造氧合器，从而增加了对该设备的需求。

北美有望在预测期内主导市场

美国是世界上受影响最严重的国家，因为非紧急手术已被搁置，减少了对这些设备的需求。 然而，随着手术在适当的规定下恢復，人工肺的需求有望进一步增加，市场增长将逐渐增加。

在整个预测期内，预计北美将主导整个氧合器市场。 增长的一个主要驱动力是糖尿病和肥胖等慢性病以及急性呼吸窘迫综合征 (ARDS) 等急性呼吸系统疾病以及 CAD、缺血性中风和心房颤动等多种心血管疾病的增加。 ，需要进行心肺旁路手术，因此增加了对人造肺的需求。 例如，根据疾病控制和预防中心的数据，到 2021 年，心脏病将导緻美国四分之一的死亡。 冠心病是美国心血管疾病相关死亡的主要原因，导致 360,900 人死亡，其次是中风 (805,000)。 在此背景下，对有效剂量的更好治疗的需求正在增加，推动了美国市场的发展。

此外，有利的报销政策、食品药品监督管理局 (FDA) 的批准、该地区医疗基础设施的可用性等预计将在预测期内提振市场。

制氧机市场竞争分析

制氧器市场竞争激烈，由几家主要参与者组成。 一些主要参与者正在推出采用先进技术的新产品以与现有产品竞争，而其他一些则正在收购或与市场上流行的其他公司合作。 目前主导市场的公司包括 Medtronic PLC、Terumo Medical Corporation、Getinge AB、EUROSETS SRL 和 Livanova PLC。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 全球心肺疾病患病率上升
    • 老龄化人口不断增加，全球医疗保健支出不断增加，可支配收入不断增加
    • 技术先进产品的可用性和报销政策
  • 市场製约因素
    • 介绍微创手术和与供氧系统相关的风险
    • 严格的 FDA 法规
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（按价值计算的市场规模：百万美元）

  • 产品类型
    • 气泡充氧器
    • 膜氧合器
  • 用法
    • 呼吸系统
    • 心
    • 体外心肺復苏 (ECPR)
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Chalice Medical Ltd
    • EUROSETS SRL
    • Getinge AB
    • Livanova PLC
    • Medtronic PLC
    • Microport Scientific Corporation
    • Nipro Medical Corporation
    • Terumo Medical Corporation
    • Braile Biomedica
    • Xenios AG
    • MC3 Cardiopulmonary
    • Gen World Medical Devices
    • Senko Medical Instrument Mfg Co. Ltd（MERA）
    • Owgels Group

第7章 市场机会今后动向

简介目录
Product Code: 68208

The oxygenators market is expected to register a CAGR of 5.4% during the forecast period 2022-2027.

To cope with the current COVID-19 situation, companies are increasing the production of oxygenators globally to support the adoption of ECMO procedures for the treatment of COVID-19 patients. There has been a huge increase in the demand for oxygenators in ICU units. In addition, these devices have the most significant aspects of critical care in surgical procedures and the management of COVID-19 patients; therefore, market players are launching products associated with oxygenators. COVID-19 also impacted the production of oxygenator products in 2020. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected medical devices such as oxygenators, especially in the first half of 2020.

The major factors driving the growth of the market are the global prevalence of various coronary heart diseases and strokes due to changing lifestyles, leading to a rise in surgical interventions, favorable reimbursement initiatives, and rapid growth of the geriatric population. For instance, according to the World Health Organization, nearly 17.9 million people died from cardiovascular diseases in 2019, representing 32% of all global deaths, which directly resulted in higher demand for coronary artery bypass procedures, leading to a rising focus on oxygenators for efficient treatments, fueling the growth of the market throughout the forecast period.

Moreover, there is a rising burden of cardiovascular diseases across the world, and they are the leading causes of death. As per the 2020 statistics provided by the World Health Organization (WHO), ischemic heart disease is responsible for 16% of the world's total deaths. As per the same source, an estimate of 8.9 million deaths were reported for ischemic heart disease in 2019. The rising prevalence of cardiovascular diseases is driving cardiopulmonary surgeries and coronary artery bypass grafting (CABG), which may increase the demand for oxygenators.

However, the adoption of minimally invasive procedures, like percutaneous coronary interventions, risks associated with oxygenation systems, and stringent US FDA regulations for Class II category devices, which should comply with the performance standards, are acting as barriers to the overall market growth.

Oxygenators Market Trends

The Membrane Oxygenators Segment is Expected to Hold the Largest Market Share

The membrane oxygenators segment is expected to witness the largest market share during the forecast period due to their rising adoption in CABG procedures and extracorporeal circulation for cardiopulmonary support in various surgical procedures, along with heart-lung machines, due to advantages such as reduction of the damage of tissues and thrombosis compared to bubble oxygenators. Also, their rapid deployability, effective gas exchange in a relatively small membrane surface area, enhanced blood flows, less hemolysis, and less post-operative bleeding further boost the growth of the segment.

Based on application, the respiratory segment is expected to hold a major market share during the forecast period. This can be attributed to the rise in the prevalence of chronic obstructive pulmonary disease (COPD) and cardiopulmonary diseases.

Moreover, in April 2020, an Indian firm, Genrich Membranes, which is being funded by the Department of Science and Technology (DST), India, developed membrane oxygenator equipment for the treatment of COVID-19 patients. Hence, companies are working on manufacturing oxygenators as the surgeries that were put on hold during the initial days are now resuming, and thus, the demand for these devices is rising.

North America is Expected to Dominate the Market Over the Forecast Period

The United States has been the most affected country across the world, as the non-emergent surgical procedures were put on hold, due to which the demand for these devices will decrease. However, the surgical procedures are resuming now with proper regulating guidelines, which will further increase the demand for these oxygenators, and the market growth will gradually rise.

North America is expected to dominate the overall oxygenators market throughout the forecast period. The major factors attributing to the growth are rise in the global prevalence of multiple cardiovascular indications like CAD, ischemic strokes, and atrial fibrillation, along with acute respiratory disorders such as acute respiratory distress syndrome (ARDS), due to a rise in chronic diseases, such as diabetes and obesity, necessitating the cardiopulmonary bypass procedures and thus, rise in demand for oxygenators. For instance, according to the Center for Disease Control and Prevention, 2021, heart disease accounts for one in four deaths in the United States. Coronary heart disease is the leading cause of deaths attributable to cardiovascular disease in the United States causing 360,900 deaths, followed by stroke (805,000). This scenario is leading to a higher demand for better treatment with efficient medication, which is driving the market in the United States.

Furthermore, favorable reimbursement policies, approvals by the Food and Drug Administration (FDA), and availability of healthcare infrastructure in the region are expected to fuel the market during the forecast period.

Oxygenators Market Competitor Analysis

The oxygenators market is moderately competitive and consists of several major players. Few of the key players are launching new products with advanced technologies to compete with the existing products, while others are acquiring and partnering with other companies trending in the market. Some of the companies currently dominating the market are Medtronic PLC, Terumo Medical Corporation, Getinge AB, EUROSETS SRL, and Livanova PLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Global Prevalence of Cardiopulmonary Disorders
    • 4.2.2 Increasing Geriatric Population, Rise in Global Healthcare Expenditure, and Growth in Disposable Income
    • 4.2.3 Availability of Technologically Advanced Products and Reimbursement Policies
  • 4.3 Market Restraints
    • 4.3.1 Adoption of Minimally Invasive Procedures and Risks Associated with Oxygenation Systems
    • 4.3.2 Stringent FDA Regulations
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 Product Type
    • 5.1.1 Bubble Oxygenator
    • 5.1.2 Membrane Oxygenator
  • 5.2 Application
    • 5.2.1 Respiratory
    • 5.2.2 Cardiac
    • 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Chalice Medical Ltd
    • 6.1.2 EUROSETS SRL
    • 6.1.3 Getinge AB
    • 6.1.4 Livanova PLC
    • 6.1.5 Medtronic PLC
    • 6.1.6 Microport Scientific Corporation
    • 6.1.7 Nipro Medical Corporation
    • 6.1.8 Terumo Medical Corporation
    • 6.1.9 Braile Biomedica
    • 6.1.10 Xenios AG
    • 6.1.11 MC3 Cardiopulmonary
    • 6.1.12 Gen World Medical Devices
    • 6.1.13 Senko Medical Instrument Mfg Co. Ltd (MERA)
    • 6.1.14 Owgels Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS